In 1969 was created Sedgwick Claims Management Services, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Memphis. The venture was found in North America in United States.
Among the various public portfolio startups of the fund, we may underline LeanTaaS, Snapsheet The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Computer, SaaS.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2015.
The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Sedgwick Claims Management Services, startups are often financed by USAA, Commerce Ventures, Tola Capital. The meaningful sponsors for the fund in investment in the same round are Tola Capital, State Auto Labs, OCA Ventures. In the next rounds fund is usually obtained by New York Presbyterian Ventures, Insight Partners.
| Fund Name | Location |
| Beijing Huaben Ronghe Touzi Guanli Youxian Gongsi | Beijing, China, Pinggu |
| Bell Atlantic Corporation | District of Columbia, United States, Washington |
| Brightlands Venture Partners | - |
| Bunker Hill Capital | Boston, Massachusetts, United States |
| FunP | - |
| International Copper Association | - |
| Mistral Equity Partners | New York, New York, United States |
| Nypro | Clinton, Massachusetts, United States |
| The Ventures Co. | - |
| Zhuhai Jinghe Ziben | China, Guangdong, Zhuhai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
EvolutionIQ | $21M | 12 Apr 2022 | New York, New York, United States | ||
DJS Antibodies | $8M | 22 Dec 2020 | Oxford, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
EvolutionIQ | $21M | 12 Apr 2022 | New York, New York, United States | ||
DJS Antibodies | $8M | 22 Dec 2020 | Oxford, England, United Kingdom |
